FDA Inspection 1242786 — Charles M. Fogarty, M.D.
The FDA completed an inspection of Charles M. Fogarty, M.D. on June 6, 2024 in Spartanburg, SC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- June 6, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Spartanburg, SC (United States)
Additional Details
Clinical BA/BE